Clinical Trials Directory

Trials / Completed

CompletedNCT02239913

Topiramate-Phentermine Combinations for Cocaine Dependence

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
38 (actual)
Sponsor
University of Kentucky · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study will determine the influence of topiramate (Topamax®) and phentermine (Adipex®), alone and in combination, on the reinforcing, subjective and physiological effects of cocaine.

Conditions

Interventions

TypeNameDescription
DRUGCocaineThe pharmacodynamic effects of cocaine will be determined during maintenance on placebo and topiramate.
DRUGPlaceboThe pharmacodynamic effects of placebo will be determined during maintenance on placebo and topiramate.
DRUGPhentermineThe pharmacodynamic effects of phentermine maintenance will be determined during maintenance on placebo and topiramate.
DRUGTopiramateThe pharmacodynamic effects of chronic topiramate will be determined.

Timeline

Start date
2014-09-01
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2014-09-15
Last updated
2019-11-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02239913. Inclusion in this directory is not an endorsement.